Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Nov;43(11):e70138.
doi: 10.1002/cbf.70138.

Alterations in Cardiovascular Parameters in 5xFAD Murine Model

Affiliations

Alterations in Cardiovascular Parameters in 5xFAD Murine Model

Andrea G Marshall et al. Cell Biochem Funct. 2025 Nov.

Abstract

Alzheimer's Disease (AD) is a global health issue, affecting over 6 million people in the United States, with that number expected to increase as the population ages. As a neurodegenerative disorder that affects memory and cognitive functions, it is well established that AD is associated with cardiovascular risk factors beyond only cerebral decline. In this study, we measured hemodynamic parameters related to cardiovascular and cerebrovascular function in 5xFAD mice with AD and their littermates. Specifically, we measured cardiovascular pulse wave velocity parameters, a marker of arterial stiffness and cardiovascular risk, and cerebrovascular pulse wave velocity, a novel technique to measure cerebral arterial stiffness. Our results showed that while 5xFAD mice exhibited significant differences in ejection time, pulse pressure, and Tei index, many other cardiovascular and cerebral parameters were not different. Despite reports that amyloid plaque deposition begins at an early age of 1.5 months in 5xFAD mice, our results did not indicate significant cardiovascular changes. Studies to elucidate cardiovascular and cerebrovascular parametric changes should be done at later ages where the underlying changes are more profound.

Keywords: 5xFAD; alzheimer's disease; cardiovascular disease; pulse wave velocity.

PubMed Disclaimer

Figures

Figure 1
Figure 1
General parameters in wild‐type and 5xFAD mice. (A,A′) Body weight, (B,B′) aortic cross‐sectional area, and (C,C′) heart rate (HR) in male and female mice. Data are mean ± SEM (n = 5–10/group). *p < 0.05, **p < 0.01, ****p < 0.0001, ns = not significant by unpaired t‐test.
Figure 2
Figure 2
Aortic flow velocity parameters. (A,A′) Peak aortic outflow velocity, (B,B′) mean aortic flow velocity, (C,C′) aortic stroke distance, and (D,D′) aortic ejection time in male and female mice. Data are mean ± SEM (n = 5–10/group). *p < 0.05, **p < 0.01, ****p < 0.0001, ns = not significant by unpaired t‐test.
Figure 3
Figure 3
Aortic blood pressure parameters. (A,A′) Systolic blood pressure (SBP), (B,B′) diastolic blood pressure (DBP), (C,C′) mean blood pressure (MBP), (D,D′) pulse pressure, and (E,E′) rate pressure product (RPP = HR × SBP) in male and female mice. Data are mean ± SEM (n = 5–10/group). *p < 0.05, **p < 0.01, ****p < 0.0001, ns = not significant by unpaired t‐test.
Figure 4
Figure 4
Mitral flow velocity parameters. (A,A′) Mitral peak‐early flow velocity (E wave), (B,B′) isovolumic contraction time (IVCT), (C,C′) isovolumic relaxation time (IVRT), and (D,D′) myocardial performance index (Tei index). Data are mean ± SEM (n = 5–10/group). *p < 0.05, **p < 0.01, ****p < 0.0001, ns = not significant by unpaired t‐test.

Update of

References

    1. Wong W., “Economic Burden of Alzheimer Disease and Managed Care Considerations,” American Journal of Managed Care 26 (2020): S177–S183, 10.37765/ajmc.2020.88482. - DOI - PubMed
    1. Scheltens P., Blennow K., Breteler M. M. B., et al., “Alzheimer's Disease,” Lancet 388 (2016): 505–517, 10.1016/S0140-6736(15)01124-1. - DOI - PubMed
    1. Silva M. V. F., Loures C. M. G., Alves L. C. V., de Souza L. C., Borges K. B. G., and Carvalho M. G., “Alzheimer's Disease: Risk Factors and Potentially Protective Measures,” Journal of Biomedical Science 26 (2019): 33, 10.1186/s12929-019-0524-y. - DOI - PMC - PubMed
    1. DeCarli C., “The Link Between Blood Pressure and Alzheimer's Disease,” Lancet Neurology 20 (2021): 878–879, 10.1016/S1474-4422(21)00340-9. - DOI - PubMed
    1. Bajwa E. and Klegeris A., “Neuroinflammation as a Mechanism Linking Hypertension With the Increased Risk of Alzheimer's Disease,” Neural Regeneration Research 17 (2022): 2342–2346, 10.4103/1673-5374.336869. - DOI - PMC - PubMed

LinkOut - more resources